CDEK
← All drugs Report issue

copper

Trade name: cu-7

Small moleculeapproved

Approved

Nov 15, 1984

Copper is a chemical element; it has symbol Cu and atomic number 29. It is a soft, malleable, and ductile metal with very high thermal and electrical conductivity. A freshly exposed surface of pure copper has a pinkish-orange color. Copper is used as a conductor of heat and electricity, as a building material, and as a constituent of various metal alloys, such as sterling silver used in jewelry, cupronickel used to make marine hardware and coins, and constantan used in strain gauges and thermocouples for temperature measurement. — Wikipedia

Clinical trial activity

27 trials · 44 clinical orgs · 3 marketing orgs

Phase 1
8
Phase 2
12
Phase 3
4
Phase 4
2

Earliest trial started Jan 1, 2004 (NCT03878667)

Timeline

1980s

  1. Nov 15, 1984

    CooperVision Surgical — Earliest FDA Approval

  2. Nov 15, 1984

    CooperVision Surgical — NDA Secondary Org

  3. Nov 15, 1984

    CooperVision Surgical — NDA Organization

2000s

  1. Jan 1, 2004

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2013

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Feb 24, 2025

    Sebela Pharmaceuticals — Marketing Organization

Indications

Approved for

Studied for

Mechanism of action

  • CopperSupplementation

    Copper supplementation

Approval history

  • approvedNov 15, 1984

Chemistry & pharmacology

Loading structure…

SMILES

[Cu++].CN\C([S-])=N\N=C(C)\C(C)=N\N=C(/[S-])NC
Mol. weight
321.913 g/mol
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Availability
Prescription Only

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • cobre
  • cobre
  • copper
  • copper
  • copper
  • copper
  • copper
  • cu-7
  • cu-7
  • cu(ii)atsm
  • cuivre
  • cuivre
  • cuprum
  • cuprum
  • kupfer
  • kupfer
  • paragard t 380a
  • paragard t 380a
  • tatum-t
  • tatum-t

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05661682Phase 4Sep 30, 2023American Regent, Inc.
NCT05677126Phase 4Sep 30, 2023American Regent, Inc.
NCT04511468N/AJun 23, 2021Blackmores Institute, University of Indonesia
NCT04775238N/AFeb 27, 2021Sohag University
NCT04313166Phase 2Mar 19, 2020Collaborative Medicinal Development Pty Limited, Macquarie University
NCT04265274Phase 2Jan 1, 2020National Cancer Institute, Slovakia
NCT04082832Phase 2/Phase 3 (Phase 3)Sep 16, 2019Collaborative Medicinal Development Pty Limited, Macquarie University
NCT03785366Phase 3Dec 17, 2018Sebela Pharmaceuticals, Synteract, Inc.
NCT03204929Phase 1Jul 5, 2017Collaborative Medicinal Development Pty Limited, Melbourne Health
NCT03136809Phase 1/Phase 2 (Phase 2)May 8, 2017Collaborative Medicinal Development Pty Limited, Macquarie University
NCT03034135Phase 2Mar 9, 2017Cantex Pharmaceuticals, Washington University in St. Louis
NCT02963051Phase 1Feb 1, 2017Duke University, Give 1 For Dad Campaign, Peter Michael Foundation, V Foundation
NCT02678975Phase 2/Phase 3 (Phase 3)Jan 1, 2017Karolinska Institute, Linkoping University, Lund University, Norwegian University of Science and Technology, University of Gothenburg
NCT01777919Phase 2Jan 1, 2017Olympion Medical Center, University of Eastern Finland, University of Ioannina, University of Ulm
NCT02870634Phase 1Oct 1, 2016Collaborative Medicinal Development Pty Limited, Macquarie University
NCT02332148Phase 1Feb 1, 20153VM Research Group, Inc., CDA Research Group, Inc.
NCT02197182Early Phase 1 (Phase 1)Jun 1, 2014CDA Research Group, Inc.
NCT02714543Phase 3Nov 1, 2013The Oxford Dental College, Hospital and Research Center, Bangalore, India
NCT01762670Phase 1/Phase 2 (Phase 2)Feb 1, 2013CDA Research Group, Inc., Temple University
NCT01666587N/AAug 1, 2012Thompson Rivers University, University of Essex
Showing 20 of 27 trials
Page 1 / 2

Organizations

Research & Development (44)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Collaborative Medicinal Development Pty LimitedFor profit5532016
Macquarie UniversityAcademic/Hospital4032016
CDA Research Group, Inc.For profit3322013
American Regent, Inc.For profit2212023
Texas A&M UniversityAcademic/Hospital2212004
3VM Research Group, Inc.For profit1012015
AlconFor profit1012004
BayerFor profit1012004
Blackmores InstituteAcademic/Hospital1012021
Cantex PharmaceuticalsFor profit1112017
Curves InternationalFor profit1012009
Duke UniversityAcademic/Hospital1112017
Give 1 For Dad CampaignAcademic/Hospital1012017
Instituto de Investigacion Nutricional, PeruAcademic/Hospital1012004
Instituto Mexicano del Seguro SocialGovernment1012011
Johns Hopkins UniversityAcademic/Hospital1112004
Karolinska InstituteAcademic/Hospital1012017
Linkoping UniversityAcademic/Hospital1012017
Lund UniversityAcademic/Hospital1012017
Melbourne HealthAcademic/Hospital1012017
44 organizations
Page 1 / 3

Marketing (4)

OrganizationOrg typeRelationshipDate
CooperVision SurgicalFor profitNDA2Nov 15, 1984
CooperVision SurgicalFor profitNDANov 15, 1984
G D SearleFor profitNDA2—
Sebela PharmaceuticalsFor profitMKTGFeb 24, 2025